Step 1

Draft

Step 2

Unite with Fellow Investors

Step 3

Choose the Best Attorney

Step 4

Provide Documents

Step 5

Follow Case Progress

Step 6

Get Payout

OZYMF.US

id: 735

Orphazyme A/S (ORPH) $2.5M IPO Settlement

The settlement funds have been distributed to claimants.

$2,500,000

Cash Settlement

N.D. Illinois

Court

1:21-CV-03640

Case number

09/29/2020

Class period Start

11/04/2021

Class period End

01/17/2024

Claim deadline

Orphazyme A/S (ORPH) agreed to settle $2.5 million with investors to end claims over misleading statements during its IPO in 2020.

Case Type

US Securities Class Action

Case Status

Disbursed

Alleged Offence

Misleading Statements,

Failure to Disclose,

Omissions

Suspected Party

Directors,

Management

Security Type

Depository Securities (ADS, ADR, GDR)

Trade Direction

Long

Payout per Share

0.12

Filing date

07/09/2021

Plaintiffs

Marko Busic

Attorneys

Bronstein, Gewirtz & Grossman, LLC (New York, NY), Pomerantz LLP (Chicago, IL)

Defendants

Christophe Bourdon, Anders Vadsholt, Kim Stratton, Thomas Blaettler, Molly Painter, Georges Gemayel, Bo Jesper Hansen, Martin Bonde, Rémi Droller, Sten Verland, Martijn Kleijwegt, Anders Hedegaard, Catherine Moukheibir, Carrolee Barlow

Judge

Hon. John F. Kness

Administrator

A.B. Data Ltd

Settlement agreement date

2023-05-12

Trades matching type

FIFO

Disbursement date

09/20/2024

Trusted by industry leaders

Endorsed by top professionals who trust our innovative solutions to drive impactful results.